Nexreg releases regulatory news educating organizations on the changes in regulations, and how to keep their industrial and consumer products compliant.

Mar. 03 – EU Commission presents Rapid Alert System Report for 2005

The number of dangerous products identified in the EU has risen sharply over the last year, according to the Report on the “Rapid Alert System” (RAPEX) for non-food consumer products published today by the Commission. Through RAPEX, national authorities notify to the Commission products presenting a serious risk for the health and safety of consumers, […]

Mar. 01 – When it comes to cosmetic ingredients, buyer beware (Cosmetics labels)

The Sacramento Bee discusses new regulations in play for cosmetics manufacturers that sell in the California market: Certainly, the issue of ingredient safety continues to be a hot-button topic in California. In August, the state Legislature approved SB 484, better known as the Safe Cosmetics Act. The bill, by Sen. Carole Migden, D-San Francisco, faced […]

Mar. 01 – EPA Calls On Industry to Reduce Chemical Use

(Washington, D.C. – March 1, 2006) The U.S. Environmental Protection Agency unveiled the National Challenge Commitment for Priority Chemicals, a collaborative initiative to shrink industrial use of 31 priority chemicals. The challenge commitment seeks a 10 percent decrease in the use of one or more of the chemicals over three years at government and industrial […]

Feb. 28 – Unilever Recalls Dove Facial Cleansing Massager

WASHINGTON, D.C. – The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed. Name of Product: Dove™ SkinVitalizer – Facial Cleansing Massager Units: About 438,000 units (about 50,000 of which have been […]

Feb. 27 – OSHA Issues Final Standard on Hexavalent Chromium

WASHINGTON — The Occupational Safety and Health Administration (OSHA) will publish a final standard for occupational exposure to hexavalent chromium in the Feb. 28, 2006, Federal Register. The standard covers occupational exposure to hexavalent chromium (Cr(VI)) in general industry, construction and shipyards. The standard will be published in accord with the timetable established by the […]

Feb. 22 – Groups seek warning Prop. 65 label for non-stick products

A recent article in the Oroville Mercury Register discusses possible changes to California’s Prop 65: “Non-stick pans, wind-proof coats, even that 40-pound sack of dogfood hauled home from Costco the other day all need a state Proposition 65 warning because they conceal a potential human carcinogen, a coalition of labor and environmental groups said Wednesday. […]

Feb. 22 – FDA Approves First Generic Version of Flonase

The Food and Drug Administration (FDA) today approved Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase, giving American consumers an additional, lower cost alternative when choosing prescription drug products. “Except for their price, which is much lower, generic drugs are in every way equivalent to their brand name counterparts,” […]

Feb. 22 – The fat of the land (Food labels)

Might there be new food labels regulations coming out of Canada?  The Toronto Star thinks so: Canadians have little in common with the Olympic athletes competing in our name, says Mary Bush, director of the office of nutrition policy and promotion at Health Canada, and a mover in the new food labelling regulations. “The average […]

Feb. 21 – FDA Approves New Treatment for Fungal Infections

The Food and Drug Administration approved Eraxis™ (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems. “This product offers a new alternative therapy for several types of infections associated with Candida”, said Dr. Steven Galson, director of the FDA’s […]

Feb. 17 – Bristol-Myers Squibb Co. announces labeling changes for Tequin

Today, Bristol-Myers Squibb Co. announced labeling changes for Tequin (gatifloxacin), an antibiotic indicated for the treatment of patients with pneumonia, bronchitis, uncomplicated gonorrhea, and various infections including infections of urinary tract, kidneys, and skin. Information about the risks of low blood sugar and high blood sugar was added to the WARNINGS section of the U.S. […]